Related Experiment Videos
Molecular genetics of small bowel cancer
N Arber1, A I Neugut, I B Weinstein
1Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Abstract:
Although the molecular genetic changes that take place during carcinogenesis in the large bowel have been well elucidated, very little work has been done on the carcinogenesis process in the small bowel where this phenomenon is much rarer. The few studies that have been done to suggest that certain oncogenes, i.e., erbB2, K-ras, cyclin D1, and p53, are all altered in ways and in frequency similar to these phenomena in large bowel cancer. Some tumor markers have been noted to occur in malignant carcinoid tumours as well. Given the overall similarities in the epidemiology and the role of the adenoma-carcinoma sequence for both small bowel adenocarcinoma and colorectal adenocarcinoma, it is highly likely that the same molecular genetic changes play a major role. Further work is needed to confirm this. If true, a potentially important are of future research would be to determine why these molecular genetic changes occur so much less frequently in the small bowel as compared to the large bowel.
Insights
Small bowel cancer shares molecular similarities with large bowel cancer, involving key oncogenes like K-ras and p53. Further research is needed to understand why these changes are less frequent in the small intestine.
Area of Science:
- Gastroenterology
- Oncology
- Molecular Biology
Background:
- Carcinogenesis in the large bowel is well-understood, but less is known about small bowel cancer.
- Small bowel cancer is significantly rarer than large bowel cancer.
Purpose of the Study:
- To investigate the molecular genetic similarities and differences in carcinogenesis between small bowel and large bowel cancer.
- To identify key oncogenes and tumor markers involved in small bowel adenocarcinoma.
Main Methods:
- Review of existing literature on molecular genetic alterations in small bowel and large bowel cancers.
- Comparative analysis of oncogene (erbB2, K-ras, cyclin D1, p53) alterations and tumor markers.
Main Results:
- Preliminary studies suggest similar alterations in oncogenes (erbB2, K-ras, cyclin D1, p53) in both small and large bowel cancers.
- Some tumor markers are also observed in malignant carcinoid tumors of the small bowel.
- The adenoma-carcinoma sequence appears relevant for both small bowel and colorectal adenocarcinoma.
Conclusions:
- Small bowel adenocarcinoma likely shares similar molecular genetic drivers with colorectal adenocarcinoma.
- Further research is crucial to confirm these molecular similarities and investigate the lower frequency of these changes in the small bowel.